These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 21277534)

  • 1. Pathways to melanoma.
    Ko JM; Velez NF; Tsao H
    Semin Cutan Med Surg; 2010 Dec; 29(4):210-7. PubMed ID: 21277534
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Dysplastic nevus syndrome].
    Kint A
    Z Hautkr; 1986 May; 61(9):595-8. PubMed ID: 3716535
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reviewing the somatic genetics of melanoma: from current to future analytical approaches.
    Dutton-Regester K; Hayward NK
    Pigment Cell Melanoma Res; 2012 Mar; 25(2):144-54. PubMed ID: 22248438
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The molecular basis of melanomagenesis and the metastatic phenotype.
    Crowson AN; Magro C; Miller A; Mihm MC
    Semin Oncol; 2007 Dec; 34(6):476-90. PubMed ID: 18083371
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of thyrotropin-releasing hormone by human melanoma and nevi.
    Ellerhorst JA; Naderi AA; Johnson MK; Pelletier P; Prieto VG; Diwan AH; Johnson MM; Gunn DC; Yekell S; Grimm EA
    Clin Cancer Res; 2004 Aug; 10(16):5531-6. PubMed ID: 15328193
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor progression in the human melanocytic system.
    Kath R; Rodeck U; Menssen HD; Mancianti ML; Linnenbach AJ; Elder DE; Herlyn M
    Anticancer Res; 1989; 9(4):865-72. PubMed ID: 2554787
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Nevus and malignant cutaneous melanoma].
    Morales Suárez-Varela MM; Llopis González A; Lacasaña Navarro M; Ferrándiz Ferragud J
    Rev Sanid Hig Publica (Madr); 1991; 65(3):233-8. PubMed ID: 1801183
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular mechanisms in melanoma.
    Diaz-Cano SJ
    N Engl J Med; 2006 Sep; 355(13):1395; author reply 1396. PubMed ID: 17005965
    [No Abstract]   [Full Text] [Related]  

  • 9. Dysplastic nevi and other risk markers for melanoma.
    Seykora J; Elder D
    Semin Oncol; 1996 Dec; 23(6):682-7. PubMed ID: 8970587
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Melanoma susceptibility as a complex trait: genetic variation controls all stages of tumor progression.
    Ferguson B; Ram R; Handoko HY; Mukhopadhyay P; Muller HK; Soyer HP; Morahan G; Walker GJ
    Oncogene; 2015 May; 34(22):2879-86. PubMed ID: 25088201
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Growth control by tumor suppressors in malignant melanoma.
    Coleman A; Robertson G; Lugo TG
    Receptor; 1995; 5(1):9-19. PubMed ID: 7613487
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Where have dysplastic nevi led us?
    Tucker MA
    Princess Takamatsu Symp; 1987; 18():251-9. PubMed ID: 3506542
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recent progress in understanding the pathology of malignant melanoma.
    Kuphal S; Bosserhoff A
    J Pathol; 2009 Dec; 219(4):400-9. PubMed ID: 19771562
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic pathways to melanoma tumorigenesis.
    Hussein MR
    J Clin Pathol; 2004 Aug; 57(8):797-801. PubMed ID: 15280398
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinico-genetic aspects of cutaneous melanoma. II. Interconnection and pathogenetic commonality with dysplastic nevus syndrome].
    Kharkevich GIu; Kazubskaia TP; Agapova RK; Musatov VK; Trubnikov VI; Demidov LV; Gar'kavtseva RF
    Genetika; 1995 Nov; 31(11):1562-5. PubMed ID: 8666223
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiple features of advanced melanoma recapitulated in tumorigenic variants of early stage (radial growth phase) human melanoma cell lines: evidence for a dominant phenotype.
    Bani MR; Rak J; Adachi D; Wiltshire R; Trent JM; Kerbel RS; Ben-David Y
    Cancer Res; 1996 Jul; 56(13):3075-86. PubMed ID: 8674065
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of atypical mole syndrome and cutaneous naevi in the development of melanoma.
    Easton D
    Cancer Surv; 1996; 26():237-49. PubMed ID: 8783577
    [No Abstract]   [Full Text] [Related]  

  • 18. [After diagnosing melanoma in a patient: evaluation of risks of second melanoma and melanoma in the family].
    Cesarini JP; Beltzer-Garelly E; Binet O
    Ann Dermatol Venereol; 1995; 122(5):305-9. PubMed ID: 8572471
    [No Abstract]   [Full Text] [Related]  

  • 19. [Dysplastic nevi--clinical and histological picture].
    Krajsová I; Stanová M
    Sb Lek; 1988; 90(2-3):54-8. PubMed ID: 3368744
    [No Abstract]   [Full Text] [Related]  

  • 20. Correction: Hereditary cutaneous malignant melanoma-dysplastic nevus.
    Hodge SE; Bale SJ; Goldstein AM; Tucker MA
    N Engl J Med; 1991 Mar; 324(13):925. PubMed ID: 2000119
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.